261 related articles for article (PubMed ID: 11242081)
1. NO-independent regulatory site on soluble guanylate cyclase.
Stasch JP; Becker EM; Alonso-Alija C; Apeler H; Dembowsky K; Feurer A; Gerzer R; Minuth T; Perzborn E; Pleiss U; Schröder H; Schroeder W; Stahl E; Steinke W; Straub A; Schramm M
Nature; 2001 Mar; 410(6825):212-5. PubMed ID: 11242081
[TBL] [Abstract][Full Text] [Related]
2. Functional characterization of nitric oxide and YC-1 activation of soluble guanylyl cyclase: structural implication for the YC-1 binding site?
Lamothe M; Chang FJ; Balashova N; Shirokov R; Beuve A
Biochemistry; 2004 Mar; 43(11):3039-48. PubMed ID: 15023055
[TBL] [Abstract][Full Text] [Related]
3. NO-independent regulatory site of direct sGC stimulators like YC-1 and BAY 41-2272.
Becker EM; Alonso-Alija C; Apeler H; Gerzer R; Minuth T; Pleiss U; Schmidt P; Schramm M; Schröder H; Schroeder W; Steinke W; Straub A; Stasch JP
BMC Pharmacol; 2001; 1():13. PubMed ID: 11801189
[TBL] [Abstract][Full Text] [Related]
4. Nitric oxide-independent stimulation of soluble guanylate cyclase with BAY 41-2272 in cardiovascular disease.
Boerrigter G; Burnett JC
Cardiovasc Drug Rev; 2007; 25(1):30-45. PubMed ID: 17445086
[TBL] [Abstract][Full Text] [Related]
5. [Nitric oxide. The role of guanylate cyclase in its physiological effects].
Severina IS
Vopr Med Khim; 2002; 48(1):4-30. PubMed ID: 12068497
[TBL] [Abstract][Full Text] [Related]
6. Identification of residues crucially involved in soluble guanylate cyclase activation.
Rothkegel C; Schmidt PM; Stoll F; Schröder H; Schmidt HH; Stasch JP
FEBS Lett; 2006 Jul; 580(17):4205-13. PubMed ID: 16831427
[TBL] [Abstract][Full Text] [Related]
7. Resonance Raman study on synergistic activation of soluble guanylate cyclase by imidazole, YC-1 and GTP.
Pal B; Li Z; Ohta T; Takenaka S; Tsuyama S; Kitagawa T
J Inorg Biochem; 2004 May; 98(5):824-32. PubMed ID: 15134928
[TBL] [Abstract][Full Text] [Related]
8. Soluble guanylate cyclase.
Poulos TL
Curr Opin Struct Biol; 2006 Dec; 16(6):736-43. PubMed ID: 17015012
[TBL] [Abstract][Full Text] [Related]
9. Role of soluble guanylate cyclase in the molecular mechanism underlying the physiological effects of nitric oxide.
Severina IS
Biochemistry (Mosc); 1998 Jul; 63(7):794-801. PubMed ID: 9721331
[TBL] [Abstract][Full Text] [Related]
10. Localization of the heme binding region in soluble guanylate cyclase.
Zhao Y; Marletta MA
Biochemistry; 1997 Dec; 36(50):15959-64. PubMed ID: 9398330
[TBL] [Abstract][Full Text] [Related]
11. The design and synthesis of YC-1 analogues as probes for soluble guanylate cyclase.
Hering KW; Artz JD; Pearson WH; Marletta MA
Bioorg Med Chem Lett; 2006 Feb; 16(3):618-21. PubMed ID: 16326101
[TBL] [Abstract][Full Text] [Related]
12. Functions of conserved cysteines of soluble guanylyl cyclase.
Friebe A; Wedel B; Harteneck C; Foerster J; Schultz G; Koesling D
Biochemistry; 1997 Feb; 36(6):1194-8. PubMed ID: 9063867
[TBL] [Abstract][Full Text] [Related]
13. Molecular mechanisms underlying rat mesenteric artery vasorelaxation induced by the nitric oxide-independent soluble guanylyl cyclase stimulators BAY 41-2272 [5-cyclopropyl-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-4-ylamine] and YC-1 [3-(5'-hydroxymethyl-2'-furyl)-1-benzyl Indazole].
Teixeira CE; Priviero FB; Webb RC
J Pharmacol Exp Ther; 2006 Apr; 317(1):258-66. PubMed ID: 16352702
[TBL] [Abstract][Full Text] [Related]
14. Soluble guanylate cyclase activator reverses acute pulmonary hypertension and augments the pulmonary vasodilator response to inhaled nitric oxide in awake lambs.
Evgenov OV; Ichinose F; Evgenov NV; Gnoth MJ; Falkowski GE; Chang Y; Bloch KD; Zapol WM
Circulation; 2004 Oct; 110(15):2253-9. PubMed ID: 15466650
[TBL] [Abstract][Full Text] [Related]
15. NO- and haem-independent activation of soluble guanylyl cyclase: molecular basis and cardiovascular implications of a new pharmacological principle.
Stasch JP; Schmidt P; Alonso-Alija C; Apeler H; Dembowsky K; Haerter M; Heil M; Minuth T; Perzborn E; Pleiss U; Schramm M; Schroeder W; Schröder H; Stahl E; Steinke W; Wunder F
Br J Pharmacol; 2002 Jul; 136(5):773-83. PubMed ID: 12086987
[TBL] [Abstract][Full Text] [Related]
16. [The soluble form of guanylate cyclase in the molecular mechanism of the physiological effects of nitric oxide and in regulating platelet aggregation].
Severina IS
Biull Eksp Biol Med; 1995 Mar; 119(3):230-5. PubMed ID: 7795182
[No Abstract] [Full Text] [Related]
17. Binding of YC-1/BAY 41-2272 to soluble guanylate cyclase: A new perspective to the mechanism of activation.
Pal B; Kitagawa T
Biochem Biophys Res Commun; 2010 Jul; 397(3):375-9. PubMed ID: 20513359
[TBL] [Abstract][Full Text] [Related]
18. Expression and characterization of the catalytic domains of soluble guanylate cyclase: interaction with the heme domain.
Winger JA; Marletta MA
Biochemistry; 2005 Mar; 44(10):4083-90. PubMed ID: 15751985
[TBL] [Abstract][Full Text] [Related]
19. Structural changes in the heme proximal pocket induced by nitric oxide binding to soluble guanylate cyclase.
Zhao Y; Hoganson C; Babcock GT; Marletta MA
Biochemistry; 1998 Sep; 37(36):12458-64. PubMed ID: 9730818
[TBL] [Abstract][Full Text] [Related]
20. Activation of soluble guanylyl cyclase inhibits estradiol production and cyclic AMP accumulation from cultured rat granulosa cells.
Tafoya MA; Chen JY; Stewart RL; Lapolt PS
Fertil Steril; 2004 Oct; 82 Suppl 3():1154-9. PubMed ID: 15474089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]